Cargando…
Severe Refractory Hypocalcemia Caused by Denosumab
Denosumab is a fully human monoclonal antibody that binds to the receptor activator of nuclear factor kappa-Β ligand, an essential cytokine factor in bone resorption, which reduces bone resorption and has been shown to decrease the incidence of skeletal-related events in patients with malignancy and...
Autores principales: | Dadana, Sriharsha, Gundepalli, Sai, Kondapalli, Anusha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315058/ https://www.ncbi.nlm.nih.gov/pubmed/37404446 http://dx.doi.org/10.7759/cureus.39866 |
Ejemplares similares
-
The Calcium Culprit: A Case of Denosumab-induced Hypocalcemia
por: Kalayanamitra, Ricci, et al.
Publicado: (2019) -
Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment
por: Gouli, Sugam, et al.
Publicado: (2021) -
Diagnosis and Management of Denosumab-Induced Hypocalcemia and Hypophosphatemia in the Setting of Metastatic Prostate Cancer
por: Flood, Michael G, et al.
Publicado: (2022) -
Hypocalcemia Induced Bronchospasm
por: Kumari, Aneeta, et al.
Publicado: (2022) -
A Case of Sinus of Valsalva Aneurysm Rupture Causing Cardiogenic Shock
por: Dadana, Sriharsha, et al.
Publicado: (2023)